#75 Strong Clinical Relevance
High-quality evidence with meaningful patient or clinical significance.
“What we’re seeing with these arrests is a reminder that the legal cannabis market, despite its expansion, still hasn’t eliminated the illicit supply chains, and that matters clinically because patients often can’t distinguish between regulated and unregulated products, leaving them exposed to contaminants and inconsistent dosing that complicate treatment decisions.”
🚨 While individual arrest reports rarely constitute evidence for clinical decision-making, patterns of concurrent cocaine and cannabis use documented in law enforcement data can alert providers to emerging polysubstance use trends in their communities. The mention of pregnancy in this brief report underscores an important clinical concern: pregnant patients using cannabis—whether medically or recreationally—warrant careful counseling about potential risks to fetal development, particularly given cannabis’s increasing potency and the potential for concurrent use of more dangerous substances. Clinicians should recognize that arrest data alone cannot establish causation or prevalence, and social determinants, enforcement disparities, and substance use disorder pathophysiology all confound interpretation of criminal justice statistics. Nevertheless, staying informed about local drug enforcement activity and emerging polysubstance patterns can help providers better screen for and address cannabis and cocaine use during prenatal visits and routine primary care, while maintaining a non-judgmental approach that prioritizes maternal and fetal health.
💬 Join the Conversation
This topic comes up in consultations often.
Dr. Caplan offers clinical context on evolving cannabis policy and its real-world implications for patients.
Book a consultation →Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
